Determinants of COVID-19 Vaccine Uptake and Acceptability in the Horn of Africa: Evidence from Somaliland
Abstract
:1. Introduction
2. Data and Method
2.1. Sample and Data Collection
2.2. Measurement of Variables
2.3. Statistical Analysis
3. Results
3.1. Descriptive Statistics
3.2. Group Comparisons
3.3. Regression Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Variable | Question/Statement | Code |
---|---|---|
Vaccine uptake | Have you taken the COVID-19 vaccine? | 1 = yes, 0 = no |
Willingness | Are you willing to take the vaccine? | 1 = yes, 0 = no |
Gender | Participants gender | 0 = female, 1 = male |
Age | Age group | 0 = 18–24, 1 = 25–34, 2 = 35–44, 3 = 45–55, 4 = older than 55 |
Education | Level of education | 0 = no education, 1 = primary, 2 = secondary, 3 = undergraduate, 4 = postgraduate |
Marital status | Marital status | 0 = single, 1 = married, 2 = divorced, 3 = widowed |
Employment | Are you currently employed? | 1 = yes, 0 = no |
Health condition | Have you ever been diagnosed with any of the following underlying health conditions (Choose all that apply)?: heart disease, hypertension, diabetes, cancer, HIV/AIDS, Tuberculosis). | 1 if the respondent chooses at least one of the underlying health conditions specified, 0 otherwise |
Availability | Was the vaccine made available at work/study place or at a nearby health center? | 1 = yes, 0 = no |
Perceived threat | COVID-19 poses a serious threat to my health | 3 = strongly agree, 2 = agree, 1 = disagree, 0 = strongly disagree |
Perceived vaccine safety | COVID-19 vaccine is not safe | 3 = strongly disagree, 2 = disagree, 1 = agree, 0 = strongly agree |
Residence | Region of residence in Somaliland | 1 = Maroodi Jeeh, 2 = Togdheer, 3 = Sahil, 4 = Awdal, 5 = Sool, 6 = Sanaag |
Language | Language of questionnaire chosen | 1 = English, 2 = Somali |
Mode | Online survey vs. paper survey | 1 = paper survey, 2 = online survey |
Social media use | Approximately, how many hours do you use social media per day? | 0 = less than 2 h, 1 = 2 to 4 h, 2 = 5 to 7 h, 3 = more than 7 h |
References
- Word Health Organization. Available online: https://covid19.who.int/ (accessed on 24 April 2022).
- Ozili, P.K.; Arun, T. Spillover of COVID-19: Impact on the Global Economy (27 March 2020). Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3562570 (accessed on 26 April 2022).
- Uyoga, S.; Adetifa, I.M.; Karanja, H.K.; Nyagwange, J.; Tuju, J.; Wanjiku, P.; Aman, R.; Mwangangi, M.; Amoth, P.; Kasera, K.; et al. Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science 2021, 371, 79–82. [Google Scholar] [CrossRef] [PubMed]
- UNICEF. COVID-19 Vaccines Arrive in Somalia. Available online: https://www.unicef.org/somalia/stories/covid-19-vaccines-arrive-somalia (accessed on 24 April 2022).
- Coronavirus (COVID-19) Vaccinations-Statistics and Research Our World in Data. Available online: https://ourworldindata.org/covid-vaccinations (accessed on 27 April 2022).
- Ahmed, M.; Colebunders, R.; Gele, A.; Farah, A.; Osman, S.; Guled, I.; Abdullahi, A.; Hussein, A.; Ali, A.; Fodjo, J.S. COVID-19 vaccine acceptability and adherence to preventive measures in Somalia: Results of an online survey. Vaccines 2021, 9, 543. [Google Scholar] [CrossRef] [PubMed]
- Machida, M.; Nakamura, I.; Kojima, T.; Saito, R.; Nakaya, T.; Hanibuchi, T.; Takamiya, T.; Odagiri, Y.; Fukushima, N.; Kikuchi, H.; et al. Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic. Vaccines 2021, 9, 210. [Google Scholar] [CrossRef] [PubMed]
- Malik, A.A.; McFadden, S.M.; Elharake, J.; Omer, S.B. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine 2020, 26, 100495. [Google Scholar] [CrossRef] [PubMed]
- Dula, J.; Mulhanga, A.; Nhanombe, A.; Cumbi, L.; Júnior, A.; Gwatsvaira, J.; Fodjo, J.; Villela, E.F.D.M.; Chicumbe, S.; Colebunders, R. COVID-19 vaccine acceptability and its determinants in Mozambique: An online survey. Vaccines 2021, 9, 828. [Google Scholar] [CrossRef] [PubMed]
- Soares, P.; Rocha, J.; Moniz, M.; Gama, A.; Laires, P.; Pedro, A.; Dias, S.; Leite, A.; Nunes, C. Factors associated with COVID-19 vaccine hesitancy. Vaccines 2021, 9, 300. [Google Scholar] [CrossRef] [PubMed]
- Robinson, E.; Andrew, J.; Michael, D. International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine 2021, 39, 2024–2034. [Google Scholar] [CrossRef] [PubMed]
- Chaudhary, F.A.; Ahmad, B.; Khalid, M.D.; Fazal, A.; Javaid, M.M.; Butt, D.Q. Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population. Hum. Vaccines Immunother. 2021, 17, 3365–3370. [Google Scholar] [CrossRef] [PubMed]
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2021, 27, 225–228. [Google Scholar] [CrossRef] [PubMed]
- Grüner, S.; Felix, K. The intention to be vaccinated against COVID-19: Stated preferences before vaccines were available. Appl. Econ. Lett. 2021, 28, 1847–1851. [Google Scholar] [CrossRef]
- Alemayehu, A.; Yusuf, M.; Demissie, A.; Abdullahi, Y. Determinants of COVID-19 vaccine uptake and barriers to being vaccinated among first-round eligibles for COVID-19 vaccination in Eastern Ethiopia: A community based cross-sectional study. SAGE Open Med. 2022, 10, 20503121221077585. [Google Scholar] [CrossRef]
- Shah Anoop, S.V.; Gribben, C.; Bishop, J.; Hanlon, P.; Caldwell, D.; Wood, R.; Reid, R.; McMenamin, J.; Goldberg, D.; Stockton, D.; et al. Effect of vaccination on transmission of COVID-19: An observational study in healthcare workers and their households. MedRxiv 2021, 385, 1718–1720. [Google Scholar]
- Jama, A.; Ali, M.; Lindstrand, A.; Butler, R.; Kulane, A. Perspectives on the measles, mumps and rubella vaccination among Somali mothers in Stockholm. Int. J. Environ. Res. Public Health 2018, 15, 2428. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bahta, L.Y.N.N.; Asli, A. Addressing MMR Vaccine Resistance in Minnesota’s Somali Community. Minn. Med. 2015, 98, 33–36. [Google Scholar] [PubMed]
Group | Obs. | % Vaccinated/Willing | |
---|---|---|---|
Vaccinated | Yes | 259 | 37% |
No | 5 | 63% | |
Willing to get vaccinated | Yes | 153 | 35% |
No | 282 | 65% |
Variable | Group | Vaccinated | Willingness | ||
---|---|---|---|---|---|
Observations (% Vaccinated) | Difference Test | Observations (% Willing) | Difference Test | ||
Gender | Female | 279 (34) | −1.186 (0.236) | 181 (39) | 1.493 (0.135) |
Male | 425 (39) | 254 (32) | |||
Age | 18–24 | 296 (27) | 20.979 *** (0.0001) | 214 (33) | 6.244 (0.182) |
25–34 | 240 (40) | 140 (35) | |||
35–44 | 77 (54) | 33 (45) | |||
45–55 | 49 (43) | 28 (50) | |||
>55 | 41 (54) | 19 (21) | |||
Education | No education | 55 (18) | 23.599 *** (0.0001) | 44 (34) | 7.321 (0.120) |
Primary | 28 (33) | 19 (37) | |||
Secondary | 63 (36) | 38 (37) | |||
Undergraduate | 355 (33) | 232 (31) | |||
Postgraduate | 201 (49) | 100 (46) | |||
Employment | Yes | 416 (43) | −4.032 *** (0.0001) | 231 (34) | 0.516 (0.606) |
No | 285 (28) | 202 (36) | |||
Healthcare | Yes | 68 (54) | −2.391 ** (0.017) | 30 (37) | −0.412 (0.681) |
No | 378 (39) | 225 (33) | |||
Health Condition | Yes | 106 (45) | −1.954 (0.051) | 57 (33) | 0.312 (0.755) |
No | 598 (35) | 378 (35) | |||
Availability | Yes | 532 (86) | −4.456 *** (0.000) | 306 (69) | 0.582 (0.561) |
No | 165 (71) | 125 (72) | |||
Perceived threat | Strongly agree | 272 (48) | 22.438 *** (0.0001) | 140 (42) | 14.018 *** (0.0002) |
Agree | 241(32) | 161 (40) | |||
Disagree | 129 (28) | 91 (23) | |||
Strongly disagree | 56 (25) | 40 (15) | |||
Perceived safety | Strongly agree | 165 (32) | 5.485 ** (0.019) | 110 (23) | 7.798 *** (0.005) |
Agree | 224 (33) | 147 (36) | |||
Disagree | 207 (44) | 114 (46) | |||
Strongly disagree | 100 (39) | 60 (35) |
Model 1: Vaccine Uptake | Model 2: Vaccination Willingness | |||||
---|---|---|---|---|---|---|
Coeff. | Std. Error | Z-Test | Coeff. | Std. Error | Z-Test | |
Gender | −0.236 | 0.197 | −1.20 | −0.269 | 0.234 | −1.15 |
Age | 0.497 *** | 0.090 | 5.30 | 0.254 ** | 0.129 | 1.99 |
Education | 0.364 *** | 0.108 | 3.36 | 0.237 * | 0.135 | 1.75 |
Employment | 0.423 ** | 0.216 | 1.96 | −0.315 | 0.255 | −1.24 |
Health condition | 0.279 | 0.279 | 1.00 | −0.391 | 0.378 | −1.04 |
Perceived threat | 0.522 *** | 0.104 | 5.02 | 0.520 *** | 0.134 | 3.88 |
Perceived safety | 0.277 *** | 0.093 | 2.96 | 0.335 *** | 0.115 | 2.91 |
Availability | 0.820 *** | 0.230 | 3.56 | −0.184 | 0.246 | −0.75 |
Residence | −0.077 | 0.110 | −0.70 | 0.103 | 0.118 | 0.78 |
Language | −0.577 *** | 0.197 | −2.92 | −0.509 ** | 0.260 | −1.96 |
Mode | 0.207 | 0.199 | 1.04 | −0.089 | 0.247 | −0.36 |
Social media use | −0.051 | 0.100 | −0.50 | −0.024 | 0.118 | −0.20 |
Cons | −3.731 *** | 0.677 | −5.51 | −1.483 * | 0.804 | −1.85 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sulub, S.A.; Mohamed, M.A. Determinants of COVID-19 Vaccine Uptake and Acceptability in the Horn of Africa: Evidence from Somaliland. Vaccines 2022, 10, 1076. https://doi.org/10.3390/vaccines10071076
Sulub SA, Mohamed MA. Determinants of COVID-19 Vaccine Uptake and Acceptability in the Horn of Africa: Evidence from Somaliland. Vaccines. 2022; 10(7):1076. https://doi.org/10.3390/vaccines10071076
Chicago/Turabian StyleSulub, Saed A., and Mubarak A. Mohamed. 2022. "Determinants of COVID-19 Vaccine Uptake and Acceptability in the Horn of Africa: Evidence from Somaliland" Vaccines 10, no. 7: 1076. https://doi.org/10.3390/vaccines10071076
APA StyleSulub, S. A., & Mohamed, M. A. (2022). Determinants of COVID-19 Vaccine Uptake and Acceptability in the Horn of Africa: Evidence from Somaliland. Vaccines, 10(7), 1076. https://doi.org/10.3390/vaccines10071076